Kalaris Therapeutics, Inc. (KLRS)

Kalaris Therapeutics Statistics

Total Valuation

KLRS has a market cap or net worth of $95.57 million. The enterprise value is -$337,611.

Market Cap	95.57M
Enterprise Value	-337,611

Important Dates

The next estimated earnings date is Saturday, November 15, 2025, before market open.

Earnings Date	Nov 15, 2025
Ex-Dividend Date	n/a

Share Statistics

KLRS has 18.70 million shares outstanding. The number of shares has increased by 92.38% in one year.

Current Share Class	18.70M
Shares Outstanding	18.70M
Shares Change (YoY)	+92.38%
Shares Change (QoQ)	+361.40%
Owned by Insiders (%)	9.02%
Owned by Institutions (%)	8.61%
Float	4.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.67
P/TBV Ratio	1.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.98

Current Ratio	11.98
Quick Ratio	11.56
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.71

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-79.34%
Revenue Per Employee	n/a
Profits Per Employee	-$5.83M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-75.22%
50-Day Moving Average	4.80
200-Day Moving Average	5.56
Relative Strength Index (RSI)	50.91
Average Volume (20 Days)	172,201

Short Selling Information

The latest short interest is 405,291, so 2.17% of the outstanding shares have been sold short.

Short Interest	405,291
Short Previous Month	681,273
Short % of Shares Out	2.17%
Short % of Float	9.41%
Short Ratio (days to cover)	1.12

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-67.59M
Pretax Income	-81.66M
Net Income	-81.66M
EBITDA	n/a
EBIT	-67.59M
Earnings Per Share (EPS)	-$6.99

Balance Sheet

The company has $88.43 million in cash and n/a in debt, giving a net cash position of $88.43 million or $4.73 per share.

Cash & Cash Equivalents	88.43M
Total Debt	n/a
Net Cash	88.43M
Net Cash Per Share	$4.73
Equity (Book Value)	53.12M
Book Value Per Share	2.84
Working Capital	84.00M

Cash Flow

Operating Cash Flow	-32.16M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KLRS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-92.38%
Shareholder Yield	-92.38%
Earnings Yield	-92.70%
FCF Yield	n/a

Analyst Forecast

The average price target for KLRS is $23.00, which is 350.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$23.00
Price Target Difference	350.10%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2